Initial Experience in Percutaneous Arteriovenous Fistula (Endo-AVF) Creation with WavelinQ (BD)

Introduction: Report initial experience in percutaneous arteriovenous fistula (endo-AVF) creation with WavelinQ (BD) 4-Fr Endo-AVF System.

Method(s): From December 2020 to November 2022, 45 consecutive patients with chronic kidney disease have been screened with Ultrasound-Color-Doppler. Thirty were eligible for endo-AVF. Procedures were conducted under regional block anesthesia. All procedures were performed using WavelinQ 4-Fr system with a technical success of 30/30 cases. Mean procedural time was 1,7 ± 2 hours. Radio-radial in 21/30 cases, and ulno-ulnar in 9/30. Nineteen were performed with the parallel approach and 11 with the antiparallel approach.

Result(s): Three intraprocedural complications were observed (10%). Embolization of deep vein collaterals during the index procedure was performed in 20/30 cases. After a mean follow-up of 342 days (range 31–710), 5/26 patients did not need hemodialysis. Cannulation was successful in the remain 21 patients.

Conclusion(s): Initial experience shows endo-AVF safe, feasible with high maturation and long-term patency rates.

No conflict of interest has been declared by the author(s).

Publication History

Article published online:
09 February 2023